TG THERAPEUTICS, INC. (TGTX) /
The revenue of TG THERAPEUTICS, INC. over the past 10 years
Chart TG THERAPEUTICS, INC.: revenue, fiscal 2016–2025 Open the chart →TG THERAPEUTICS, INC. reported revenue of $616.29M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $152K — up 405352% over 9 years. Year over year, revenue rose 4 times and fell once. The largest one-year move was in fiscal 2023: up 8290%, from $2.79M to $233.66M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $616.29M |
| 2024ended Dec 31, 2024 | $329M |
| 2023ended Dec 31, 2023 | $233.66M |
| 2022ended Dec 31, 2022 | $2.79M |
| 2021ended Dec 31, 2021 | $6.69M |
| 2020ended Dec 31, 2020 | $152K |
| 2019ended Dec 31, 2019 | $152K |
| 2018ended Dec 31, 2018 | $152K |
| 2017ended Dec 31, 2017 | $152K |
| 2016ended Dec 31, 2016 | $152K |
Fiscal years as TG THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TG THERAPEUTICS, INC.
- The profitability of TG THERAPEUTICS, INC.
- The cash flow of TG THERAPEUTICS, INC.
- The debt of TG THERAPEUTICS, INC.
- All of TG THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- PRIPrimerica, Inc.
- VMIValmont Industries, Inc.
- SANMSanmina Corporation
- AOSA. O. Smith Corporation
- MORNMORNINGSTAR, INC.
Not investment advice. This page shows what TG THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.